Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes

Pediatric Research

Volumn 79, Issue 3, 2016, Pages 416-424

  Aliou, Yessoufou ^a   Liao, Min Chun ^a   Zhao, Xin Ping ^a   Chang, Shiao Ying ^a   Chenier, Isabelle ^a   Ingelfinger, Julie R ^b   Zhang, Shao Ling ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL; COLLAGEN TYPE 4; FATTY ACID; FATTY ACID BINDING PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LIPID; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BORDERLINE HYPERTENSION; CATCH UP GROWTH; CONTROLLED STUDY; FEMALE; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LIPID DIET; LIPID STORAGE; MALE; MATERNAL DIABETES MELLITUS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; BODY WEIGHT; C57BL MOUSE; COMPLICATION; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; INJURIES; KIDNEY; KIDNEY DISEASE; KIDNEY TUBULE; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL EXPOSURE; WEANING;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; BODY WEIGHT; DIABETES, GESTATIONAL; DIET, HIGH-FAT; FATTY ACID-BINDING PROTEINS; FEMALE; FETAL GROWTH RETARDATION; GLUCOSE TOLERANCE TEST; HYPERTENSION; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; WEANING;

EID: 84962709137     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2015.236     Document Type: Article

References (41)

1. Plagemann A. Maternal diabetes and perinatal programming. Early Hum Dev 2011; 87: 743-7
2. Plagemann A, Harder T, Rodekamp E, Kohlhoff R. Rapid neonatal weight gain increases risk of childhood overweight in offspring of diabetic mothers. J Perinat Med 2012; 40: 557-63
3. Plagemann A, Harder T, Schellong K, Schulz S, Stupin JH. Early postnatal life as a critical time window for determination of long-Term metabolic health. Best Pract Res Clin Endocrinol Metab 2012; 26: 641-53
4. Spencer SJ. Early life programming of obesity: the impact of the perinatal environment on the development of obesity and metabolic dysfunction in the offspring. Curr Diabetes Rev. 2012; 8: 55-68
5. Holemans K, Aerts L, Van Assche FA. Fetal growth restriction and consequences for the offspring in animal models. J Soc Gynecol Investig 2003; 10: 392-9
6. Van Assche FA, Holemans K, Aerts L. Long-Term consequences for offspring of diabetes during pregnancy. Br Med Bull 2001; 60: 173-82
7. Perala MM, Mannisto S, Kaartinen NE, et al. Body size at birth is associated with food and nutrient intake in adulthood. PLoS One 2012; 7: e46139
8. Crowther NJ, Cameron N, Trusler J, Toman M, Norris SA, Gray IP. Influence of catch-up growth on glucose tolerance and beta-cell function in 7-year-old children: results from the birth to twenty study. Pediatrics 2008; 121: e1715-22
9. Chang SY, Chen YW, Zhao XP, et al. Catalase prevents maternal diabetesinduced perinatal programming via the Nrf2-HO-1 defense system. Diabetes 2012; 61: 2565-74
10. Chen YW, Chenier I, Tran S, Scotcher M, Chang SY, Zhang SL. Maternal diabetes programs hypertension and kidney injury in offspring. Pediatr Nephrol 2010; 25: 1319-29
11. Tran S, Chen YW, Chenier I, et al. Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 2008; 19: 943-52
12. Zhang SL, Chen YW, Tran S, Chenier I, Hebert MJ, Ingelfinger JR. Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 2007; 18: 2105-15
13. Chen YW, Chenier I, Chang SY, Tran S, Ingelfinger JR, Zhang SL. High glucose promotes nascent nephron apoptosis via NF-kappaB and p53 pathways. Am J Physiol Renal Physiol 2011; 300: F147-56
14. Decleves AE, Mathew AV, Cunard R, Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol 2011; 22: 1846-55
15. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol 2011; 301: F919-31
16. Soumura M, Kume S, Isshiki K, et al. Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell. Biochem Biophys Res Commun 2010; 402: 265-71
17. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 2011; 58: 784-90
18. Chandra A, Neeland IJ, Berry JD, et al. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol 2014; 64: 997-1002
19. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 2002; 109: 1381-9
20. Kang HM, Ahn SH, Choi P, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 2015; 21: 37-46
21. Kennedy DJ, Kuchibhotla S, Westfall KM, Silverstein RL, Morton RE, Febbraio M. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res 2011; 89: 604-13
22. Kennedy DJ, Chen Y, Huang W, et al. CD36 and Na/K-ATPaseα1 form a proinflammatory signaling loop in kidney. Hypertension 2013; 61: 216-24
23. Ishimura S, Furuhashi M, Watanabe Y, et al. Circulating levels of fatty acidbinding protein family and metabolic phenotype in the general population. PLoS One 2013; 8: e81318
24. Furuhashi M, Ishimura S, Ota H, et al. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS One 2011; 6: e27356
25. Yeung DC, Xu A, Tso AW, et al. Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 2009; 32: 132-4
26. Tanaka M, Furuhashi M, Okazaki Y, et al. Ectopic expression of fatty acidbinding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction. Nephron Clin Pract 2014; 128: 345-51
27. Okazaki Y, Furuhashi M, Tanaka M, et al. Urinary excretion of fatty acidbinding protein 4 is associated with albuminuria and renal dysfunction. PLoS One 2014; 9: e115429
28. Prior LJ, Velkoska E, Watts R, Cameron-Smith D, Morris MJ. Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect? Int J Obes (Lond) 2008; 32: 1585-94
29. Velkoska E, Cole TJ, Dean RG, Burrell LM, Morris MJ. Early undernutrition leads to long-lasting reductions in body weight and adiposity whereas increased intake increases cardiac fibrosis in male rats. J Nutr 2008; 138: 1622-7
30. Bruce CR, Hoy AJ, Turner N, et al. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009; 58: 550-8
31. Murrow BA, Hoehn KL. Mitochondrial regulation of insulin action. Int J Biochem Cell Biol 2010; 42: 1936-9
32. Kennedy AJ, Ellacott KL, King VL, Hasty AH. Mouse models of the metabolic syndrome. Dis Model Mech 2010; 3: 156-66
33. Kim HJ, Vaziri ND, Norris K, An WS, Quiroz Y, Rodriguez-Iturbe B. High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol 2010; 14: 536-47
34. Hamdani N, Franssen C, Lourenco A, et al. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail 2013; 6: 1239-49
35. Baines RJ, Chana RS, Hall M, Febbraio M, Kennedy D, Brunskill NJ. CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies. Am J Physiol Renal Physiol 2012; 303: F1006-14
36. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2005; 2: e45
37. Okamura DM, Lopez-Guisa JM, Koelsch K, Collins S, Eddy AA. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. Am J Physiol Renal Physiol 2007; 293: F575-85
38. Xu A, Vanhoutte PM. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 2012; 302: H1231-40
39. el Nahas AM, Bassett AH, Cope GH, Le Carpentier JE. Role of growth hormone in the development of experimental renal scarring. Kidney Int 1991; 40: 29-34
40. Veniant M, Heudes D, Clozel JP, Bruneval P, Menard J. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int 1994; 46: 421-9
41. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M. A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes 2001; 50: 1970-5